Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin ? . g/dL (. mmol/L)
SAFETY RUN-IN: Within  days of registration: Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin ?  g/dL or ? . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L.
Hemoglobin >= . g/dL (. mmol/L)
Hemoglobin >= . g/dL or >= . mmol/L
Hemoglobin >= . g/dL (. mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
At time of registration and within  weeks prior to initiating on-protocol treatment: Hemoglobin >=  g/dL or >= . mmol/L
Within  days prior to the start of study treatment: Hemoglobin >= . g/dL or >= . mmol/L
Hemoglobin . g/dL (. mmol/L)
Within  days of registration: Hemoglobin >= . g/gL or >= . mmol/L, without recent transfusion
Hemoglobin ?. g/dL (?. mmol/L);.
Hemoglobin >=  g/dL or >= . mmol/L within  days prior to registration
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Performed  days prior to study registration up to the first dose of study drug: hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >= . g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L except in cases of marrow infiltration by lymphoma
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin <  g/dL (. mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >= . g/dL (. mmol/L)
Performed within  days prior to study registration up to the first dose of study drug: Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL (. mmol/L); subjects may not have had a transfusion within  days of screening assessment
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin ? g/dL or ? . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL OR >= . mmol/L
Hemoglobin >= . g/dL or >= . mmol/L
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin greater than . g/dL (=  g/L or . mmol/L)
Hemoglobin ? g/dL or ?. mmol/L
Hemoglobin >= g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin ? g/dL or ?. mmol/L- without qualifications
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin ? . g/dL (. mmol/L)
Hemoglobin < . g/dL (< . mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL or >= . mmol/L, performed within  days prior to registration
Performed within  days of radiation therapy: Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin >=  g/dL (or >= . mmol/L)
Hemoglobin >=  g/dL (. mmol/L); subjects may not have had a transfusion within  days of screening assessment
Hemoglobin >=  g/dL (. mmol/L); subjects may not have had a transfusion within  days of screening assessment
Hemoglobin >=  g/dL (. mmol/L); subjects may not have had a transfusion within  days of screening assessment
Hemoglobin >=  g/dL (. mmol/L); subjects may not have had a transfusion within  days of screening assessment
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin ?. g/dL (?. mmol/L)
Hemoglobin >=  g/dL or >= . mmol/L
Hemoglobin ?  g/L (?. mmol/L).
Hemoglobin ? . g/dL (. mmol/L)
Bone Marrow: Absolute neutrophil count ANC ? ,/mm (.  /L); Platelets ? ,/mm (  /L); Hemoglobin ? . g/dL (. mmol/L). Subjects with hemoglobin ? . g/dL (. mmol/L) following transfusion are eligible;
Hemoglobin ?  g/dL or ? . mmol/L
Hemoglobin >=  g/dL (. mmol/L)
Hemoglobin <  g/dL (. mmol/L)
Hemoglobin (Hgb) >=  g/dL or >= . mmol/L
Hemoglobin >= . g/dL or >= . mmol/L
Hemoglobin > . mmol/L ( g/dL) at the screening visit
Hemoglobin >= . g/dL or >= . mmol/L
